ARCA Biopharma Inc (NASDAQ:ABIO)
0.5323 Delayed Data As of Apr 26 | ![]() Today’s Change | 0.45 Today|||52-Week Range 2.76 | -60.57% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
Previous close | 0.52 |
Today’s open | 0.52 |
Day’s range | 0.52 - 0.57 |
Volume | 126,572 |
Average volume (3 months) | 846,364 |
Market cap | $7.6M |
Data as of 3:59pm ET, 04/26/2018
Growth & Valuation
Earnings growth (last year) | +0.55% |
Earnings growth (this year) | -7.73% |
Earnings growth (next 5 years) | +30.00% |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 0.27 |
Competitors
Today’s change | Today’s % change | |
---|---|---|
OGENOragenics Inc | -0.08 | -5.44% |
ANTHAnthera Pharmaceutic... | -0.01 | -1.64% |
CBIOCatalyst Biosciences... | +1.12 | +4.18% |
KZIAKazia Therapeutics L... | +0.05 | +0.92% |
Data as of 8:00pm ET, 04/26/2018
Financials
Next reporting date | May 9, 2018 |
EPS forecast (this quarter) | -- |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$16.4M |
Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Operating Officer Thomas A. Keuer |
Corporate headquarters Westminster, Colorado |
Forecasts
